Labcorp Holdings LH
$367.13 −$1.75 (-0.47%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $367.13 0.00%
Open$371.48
Prev close$368.88
Day range$366.33 – $372.50
Volume890.6K
Market cap$29.81B
P/E (TTM)30.1
Dividend yield0.78%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$3.81B+6.9% YoY
Operating profit$418.00M+3.9% YoY
Net profit$263.10M+0.6% YoY
Diluted EPS$3.22+3.2% YoY
Free cash flow$412.20M+47.0% YoY
Operating cash flow$563.80M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin29.0%
Operating margin11.3%
Net margin6.9%
Return on equity11.4%
Return on assets5.4%
Return on invested capital7.7%
Current ratio1.41
Liabilities / assets53.2%
Cash & investments$261.80M
Total debt$6.59B
Net cash (debt)-$6.33B
Free cash flow / sales8.8%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $3.81B | $3.73B | $3.54B | $13.95B | $3.52B |
| Total Operating Revenue | $3.81B | $3.73B | $3.54B | $13.95B | $3.52B |
| Cost of Revenue | $2.70B | $2.62B | $2.52B | $9.94B | $2.52B |
| Gross Profit | $1.11B | $1.11B | $1.01B | $4.01B | $993.20M |
| Operating Expense | $690.10M | $655.30M | $626.60M | $2.50B | $610.50M |
| Selling and Admin Expenses | $611.40M | $577.20M | $551.00M | $2.22B | $537.90M |
| Depreciation & Amortization & Depletion | $78.70M | $78.10M | $75.60M | $280.00M | $72.60M |
| -Depreciation & Amortization | $78.70M | $78.10M | $75.60M | $280.00M | $72.60M |
| Operating Profit | $418.00M | $456.70M | $387.20M | $1.52B | $382.70M |
| Net Non-Operating Interest Income (Expense) | -$59.10M | -$61.10M | -$55.10M | -$224.10M | -$55.00M |
| Non-Operating Interest Expense | $59.10M | $61.10M | $55.10M | $224.10M | $55.00M |
| Other Income (Expense) | -$30.90M | -$9.20M | -$12.40M | -$184.60M | -$137.10M |
| Gain on Sale of Security | $1.40M | $5.60M | $12.20M | $15.20M | $3.50M |
| Earnings from Equity Interest | -$11.00M | -$6.20M | -$5.10M | -$13.30M | -$6.10M |
| Special Income (Charges) | -$15.90M | -$5.10M | -$6.40M | -$131.50M | -$115.10M |
| -Less:Restructuring and Mergern & Acquisition | $15.90M | $5.10M | $6.40M | $127.20M | $110.80M |
| Other Non-Operating Income (Expenses) | -$5.40M | -$3.50M | -$13.10M | -$55.00M | -$19.40M |
| Pretax Profit | $328.00M | $386.40M | $319.70M | $1.11B | $190.60M |
| Tax | $64.90M | $87.30M | $41.70M | $229.80M | $25.70M |
| Net Profit | $263.10M | $299.10M | $278.00M | $877.70M | $164.90M |
| Profit from Continuing Operations | $263.10M | $299.10M | $278.00M | $877.70M | $164.90M |
| Minority Interests | $300,000.00 | $400,000.00 | $200,000.00 | $1.20M | $200,000.00 |
| Net Income to Parent Company | $262.80M | $298.70M | $277.80M | $876.50M | $164.70M |
| Net Income to Common Stockholders | $262.80M | $298.70M | $277.80M | $876.50M | $164.70M |
| Basic EPS | $3.24 | $3.66 | $3.37 | $10.54 | $2.00 |
| Diluted EPS | $3.22 | $3.64 | $3.35 | $10.46 | $1.98 |
| Dividend Per Share | $0.72 | $0.72 | $0.72 | $2.88 | $0.72 |
| -Less:Impairment of Capital Assets | – | – | – | $4.30M | $3.60M |
| Net Income from Discontinuous Operations | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $18.92B | $18.53B | $19.09B | $18.39B | $18.39B |
| Total Current Assets | $3.97B | $3.81B | $4.56B | $4.02B | $4.02B |
| Cash and Cash Equivalents & Short-Term Investments | $261.80M | $141.80M | $981.10M | $532.30M | $532.30M |
| -Cash and Cash Equivalents | $261.80M | $141.80M | $981.10M | $532.30M | $532.30M |
| Receivables | $2.56B | $2.50B | $2.45B | $2.26B | $2.26B |
| -Accounts Receivable | $2.41B | $2.34B | $2.29B | $2.10B | $2.10B |
| -Other Receivables | $145.80M | $162.40M | $161.90M | $156.90M | $156.90M |
| Inventory | $538.40M | $562.20M | $497.70M | $534.70M | $534.70M |
| Other Current Assets | $607.30M | $606.10M | $629.50M | $692.80M | $692.80M |
| Total Non-Current Assets | $14.96B | $14.72B | $14.53B | $14.37B | $14.37B |
| Net PPE | $3.14B | $3.10B | $3.07B | $3.08B | $3.08B |
| Investments and Advances | $128.30M | $139.30M | $146.60M | $153.90M | $153.90M |
| -Long Term Equity Investment | $128.30M | $139.30M | $146.60M | $153.90M | $153.90M |
| Goodwill and Other Intangible Assets | $10.89B | $10.71B | $10.59B | $10.39B | $10.39B |
| -Goodwill | $7.18B | $7.03B | $6.96B | $6.79B | $6.79B |
| -Other Intangible Assets | $3.72B | $3.68B | $3.64B | $3.60B | $3.60B |
| Other Non-Current Assets | $793.40M | $769.30M | $724.90M | $751.30M | $751.30M |
| Total Liabilities | $10.06B | $9.91B | $10.34B | $9.76B | $9.76B |
| Total Current Liabilities | $2.82B | $2.12B | $2.64B | $2.82B | $2.82B |
| Payables | $738.00M | $688.50M | $695.70M | $1.00B | $1.00B |
| -Accounts Payable | $738.00M | $688.50M | $695.70M | $840.80M | $840.80M |
| Current Accrued Expenses | $890.10M | $862.40M | $851.90M | $263.60M | $263.60M |
| Short-Term Debt and Capital Lease Obligation | $788.90M | $185.90M | $688.20M | $695.80M | $695.80M |
| -Current Debt | $601.20M | $900,000.00 | $500.40M | $500.10M | $500.10M |
| -Current Capital Lease Obligation | $187.70M | $185.00M | $187.80M | $195.70M | $195.70M |
| Current Deferred Liabilities | $402.60M | $387.80M | $405.20M | $439.10M | $439.10M |
| Total Non-Current Liabilities | $7.24B | $7.78B | $7.70B | $6.93B | $6.93B |
| Long Term Debt and Capital Lease Obligation | $5.99B | $6.58B | $6.55B | $5.83B | $5.83B |
| -Long Term Debt | $5.25B | $5.86B | $5.83B | $5.08B | $5.08B |
| -Long Term Capital Lease Obligation | $736.30M | $722.60M | $718.70M | $745.60M | $745.60M |
| Non-Current Deferred Liabilities | $528.50M | $486.70M | $456.40M | $605.00M | $605.00M |
| Other Non-Current Liabilities | $725.60M | $717.60M | $691.80M | $112.10M | $112.10M |
| Total Equity | $8.86B | $8.62B | $8.75B | $8.64B | $8.64B |
| Stockholders' Equity | $8.85B | $8.61B | $8.73B | $8.62B | $8.62B |
| Capital Stock | $7.30M | $7.30M | $7.40M | $7.50M | $7.50M |
| -Common Stock | $7.30M | $7.30M | $7.40M | $7.50M | $7.50M |
| Additional Paid-In Capital | $78.70M | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained Earnings | $8.91B | $8.70B | $8.78B | $8.64B | $8.64B |
| Gains/Losses Not Affecting Retained Earnings | -$143.40M | -$101.90M | -$63.20M | -$27.60M | -$27.60M |
| Minority Interests | $16.10M | $16.40M | $16.90M | $16.90M | $16.90M |
| -Gross PPE | – | – | – | $6.35B | $6.35B |
| -Accumulated Depreciation | – | – | – | -$3.27B | -$3.27B |
| -Total Tax Payable | – | – | – | $160.30M | $160.30M |
| Derivative Product Liabilities | – | – | – | $274.00M | $274.00M |
| Employee Benefits | – | – | – | $111.20M | $111.20M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $563.80M | $445.50M | $191.50M | $1.64B | $614.20M |
| Net cash flow from continuing operations | $563.80M | $445.50M | $191.50M | $1.64B | $614.20M |
| Net Income from Continuing Operations | $263.10M | $299.10M | $278.00M | $877.70M | $164.90M |
| Depreciation & Depletion & Amortization | $183.00M | $179.00M | $173.30M | $681.10M | $173.00M |
| Deferred Tax | $24.40M | $24.40M | $2.00M | $97.60M | $21.20M |
| Other Non-Cash Items | $69.00M | $63.30M | $59.40M | $380.10M | $178.60M |
| Change in Working Capital | -$6.50M | -$155.20M | -$352.90M | -$526.10M | $42.50M |
| -Change in Receivables | -$51.40M | -$59.90M | -$194.10M | -$122.20M | $4.30M |
| -Change in Inventory | $25.30M | -$65.10M | $35.40M | -$30.20M | -$12.30M |
| -Change in Prepaid Assets | $4.40M | $23.10M | $4.00M | -$25.20M | -$41.00M |
| -Change in Payables and Accrued Expense | $5.00M | -$35.70M | -$166.10M | -$383.10M | $44.30M |
| -Change In Other Working Capital | $10.20M | -$17.60M | -$32.10M | $34.60M | $47.20M |
| Net cash flow from investing | -$433.70M | -$366.20M | -$322.10M | -$1.19B | -$389.90M |
| Net Cash Flow from Continuing Investing Activities | -$433.70M | -$366.20M | -$322.10M | -$1.19B | -$389.90M |
| Capital Expenditure | -$151.60M | -$131.60M | -$121.00M | -$434.50M | -$123.90M |
| Net Business Purchase and Sale | -$272.60M | -$236.50M | -$208.90M | -$575.10M | -$71.20M |
| Net Other Investing Changes | -$9.50M | $1.90M | $7.80M | $8.00M | -$2.40M |
| Financing Cash Flow | -$10.00M | -$919.90M | $580.50M | -$1.46B | -$290.40M |
| Net Cash Flow from Continuing Financing Activities | -$10.00M | -$919.90M | $580.50M | -$1.46B | -$290.40M |
| Net Issuance Payments Of Debt | $0.00 | -$500.00M | $750.00M | -$1.00B | $0.00 |
| Net Common Stock Issuance | $0.00 | -$353.80M | -$98.00M | -$450.00M | -$225.00M |
| Cash Dividends Paid | -$58.20M | -$58.70M | -$61.20M | -$240.70M | -$59.30M |
| Proceeds from Stock Option Exercised | $49.50M | $1.80M | $32.90M | $54.30M | $0.00 |
| Net Other Financing Charges | -$1.30M | -$9.20M | -$43.20M | $179.40M | -$6.10M |
| Ending Cash Balance | $261.80M | $141.80M | $981.10M | $532.30M | $532.30M |
| Net Change in Cash | $120.10M | -$840.60M | $449.90M | -$1.01B | -$66.10M |
| Beginning Cash Balance | $141.80M | $981.10M | $532.30M | $1.52B | $598.10M |
| Effect of Exchange Rate Changes | -$100,000.00 | $1.30M | -$1.10M | $24.10M | $300,000.00 |
| Free Cash Flow | $412.20M | $313.90M | $70.50M | $1.21B | $490.30M |
| Cash Flow from Discontinued Operating Activities | – | – | – | $0.00 | – |
| Net Investment Purchase and Sale | – | – | – | -$192.40M | – |
| Cash Flow from Discontinued Financing Activities | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on LH.
Sign in to join the discussion.